International Clinical Trial: A multicenter, randomized, phase III clinical trial of roprostim N01 combined with high-dose dexamethasone and intravenous immunoglobulin in the treatment of newly diagnosed severe ITP

Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134746) titled 'A multicenter, randomized, phase III clinical trial of roprostim N01 combined with high-dose dexamethasone and intravenous immunoglobulin in the treatment of newly diagnosed severe ITP' on Oct. 20.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The First Affiliated Hospital of Nanchang University

Condition: immune thrombocytopenia (ITP)

Intervention: Experimental group:Roprostim N01+ high-dose dexamethasone combined with human immunoglobulin

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-11-01

Target Sample Size: Experimental group:66;Control grou...